STOCK TITAN

Shah Capital (NVAX) discloses 9.11% Novavax stake and plans votes against board

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Shah Capital files Amendment No. 6 to its Schedule 13D on Novavax, Inc., updating its ownership and activist intentions. The filing shows Shah Capital Management and related entities beneficially owning up to 14,845,097 shares of Novavax common stock, or 9.11% of the company, based on shares outstanding as of February 16, 2026.

Most shares are held through Shah Capital Opportunity Fund LP, which directly owns 14,000,000 shares, while Himanshu H. Shah personally owns 125,359 shares. The amendment discloses that all shares, other than Mr. Shah’s personal holdings, were acquired using investment capital through open-market purchases.

The filing also notes an April 8, 2026 open letter from Shah Capital to Novavax’s board stating its intention to vote against board nominees and executive compensation. The letter cites concerns such as value destruction, a pessimistic 2026 revenue forecast, low institutional credibility, cost discipline and profitability, and governance changes.

Positive

  • None.

Negative

  • None.

Insights

Shah Capital discloses a ~9% Novavax stake and escalates activism with a critical board letter.

Shah Capital Management, Shah Capital Opportunity Fund LP, and Himanshu H. Shah report beneficial ownership of up to 14,845,097 Novavax shares, or 9.11% of the common stock, based on the stated outstanding share count. This level approaches the 10% threshold often associated with significant influence.

The amendment highlights an April 8, 2026 open letter to Novavax’s board declaring an intention to vote against board nominees and executive compensation. The letter cites concerns including value destruction, a pessimistic 2026 revenue forecast, institutional credibility, cost discipline, and governance. While no new share purchases are reported in the past 60 days, the combination of a large stake and stated voting intentions suggests elevated governance pressure, and future company responses or proxy materials may provide additional context.

Shah Capital Management beneficial ownership 14,719,738 shares (9.03%) Common stock beneficially owned via fund and managed accounts
Shah Capital Opportunity Fund LP ownership 14,000,000 shares (8.59%) Directly beneficially owned Novavax common stock
Himanshu H. Shah total beneficial ownership 14,845,097 shares (9.11%) Includes 125,359 shares held directly plus shares via Shah Capital
Direct shares held by Himanshu H. Shah 125,359 shares Owned in Mr. Shah’s managed account
Shares outstanding reference 162 shares Outstanding common shares as of February 16, 2026, baseline figure
Schedule 13D regulatory
"The following constitutes Amendment No. 6 to the filed by the undersigned"
A Schedule 13D is a legal document that investors file with regulators when they buy a large enough stake in a company to potentially influence its management or decisions. It provides details about the investor’s intention, ownership stake, and plans, helping other investors understand who is gaining control and what their motives might be.
beneficially owns financial
"As of the date hereof, Shah Opportunity directly beneficially owns 14,000,000 shares of Common Stock."
Beneficially owns means a person or entity enjoys the economic benefits and control of a security even if the legal title or registration is held in another name. Think of it like having the keys and profits from a car that is registered to a friend: you use it, benefit from it, and make decisions about it even though the official paperwork lists someone else. For investors, this matters because it reveals who truly controls shares, affects voting power, potential conflicts of interest, and regulatory disclosure obligations.
Sole Voting Power financial
"Sole Voting Power 125,359.00 8 | Shared Voting Power 14,719,738.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
Shared Dispositive Power financial
"Shared Dispositive Power - 14,719,738.00"
open market purchases financial
"All shares were purchased in various transactions and for various amounts of consideration through open market purchases."
Open market purchases are buys of a company’s shares (or other securities) made on public exchanges at prevailing market prices rather than through private deals. For investors this matters because when a company buys back its own stock it reduces the number of shares available, which can boost per-share earnings and often signals management’s confidence; it also affects supply, demand and short-term liquidity much like someone quietly buying up items from a crowded marketplace.
Shah Capital Open Letter financial
"the Reporting Persons sent a letter (the "Shah Capital Open Letter") to the board of directors"





670002401

(CUSIP Number)
Himanshu H. Shah
2301 Sugar Bush Road, Suite 510
Raleigh, NC, 27612
(919) 719-6360

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
04/08/2026

(Date of Event Which Requires Filing of This Statement)


If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




schemaVersion:


SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D






SCHEDULE 13D


Shah Capital Management
Signature:/s/ Himanshu H. Shah
Name/Title:Himanshu H. Shah, President and Chief Investment Officer
Date:04/08/2026
Shah Capital Opportunity Fund LP
Signature:/s/ Himanshu H. Shah
Name/Title:Himanshu H. Shah, Managing Member
Date:04/08/2026
Himanshu H. Shah
Signature:/s/ Himanshu H. Shah
Name/Title:Himanshu H. Shah
Date:04/08/2026

FAQ

What stake in Novavax (NVAX) does Shah Capital report in this Schedule 13D/A?

Shah Capital and related entities report beneficial ownership of up to 14,845,097 Novavax common shares, representing 9.11% of the company’s common stock. This includes 14,000,000 shares held by Shah Capital Opportunity Fund LP and 125,359 shares directly owned by Himanshu H. Shah.

Who are the reporting persons in the Novavax (NVAX) Schedule 13D/A Amendment No. 6?

The reporting persons are Shah Capital Management, Inc., Shah Capital Opportunity Fund LP, and Himanshu H. Shah. Shah Capital advises the fund, and Mr. Shah serves as President and Chief Investment Officer of Shah Capital and directly owns a portion of the shares.

How did Shah Capital acquire its Novavax (NVAX) shares according to this filing?

The filing states Novavax shares were acquired through various open market purchases. All shares, except 125,359 personally owned by Himanshu H. Shah, were bought using the investment capital of the reporting persons, rather than personal funds, over multiple transactions.

What activist actions does Shah Capital signal toward Novavax (NVAX) in this amendment?

Shah Capital indicates it sent an open letter on April 8, 2026 to Novavax’s board declaring an intention to vote against board nominees and executive compensation. The letter outlines concerns over value destruction, 2026 revenue outlook, credibility, costs, profitability, and governance.

Have there been recent Novavax (NVAX) share transactions by Shah Capital before this Schedule 13D/A?

The amendment states there were no transactions in the past 60 days in Novavax shares by the reporting persons. The filing instead focuses on current beneficial ownership levels and Shah Capital’s stated voting intentions and governance concerns.

How much of Novavax (NVAX) does Shah Capital Opportunity Fund LP alone beneficially own?

Shah Capital Opportunity Fund LP directly beneficially owns 14,000,000 Novavax common shares, representing 8.59% of the company’s common stock, based on the outstanding share count referenced in the filing. Voting and dispositive power over these shares is reported as shared.